Caregen Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	77,856	82,586	79,210	69,098	59,088	60,295
Other Revenue	-0	-	-	-0	-	0
Revenue	77,856	82,586	79,210	69,098	59,088	60,295
Revenue Growth (YoY)	-1.03%	4.26%	14.63%	16.94%	-2.00%	-6.81%
Cost of Revenue	24,127	27,314	20,914	16,795	13,644	11,684
Gross Profit	53,729	55,272	58,296	52,302	45,444	48,611
Selling, General & Admin	11,200	11,227	10,257	10,776	10,712	11,442
Research & Development	5,857	7,011	5,824	6,285	5,026	3,839
Amortization of Goodwill & Intangibles	916.14	842.66	692.76	524.71	346.82	258.06
Other Operating Expenses	472.87	375.15	267.8	269.65	264.48	238.62
Operating Expenses	20,124	21,022	17,935	18,700	17,335	16,633
Operating Income	33,605	34,250	40,360	33,603	28,109	31,978
Interest Expense	-	-	-	-	-	-4.44
Interest & Investment Income	316.15	999.04	3,669	596.42	358.28	609.31
Earnings From Equity Investments	-346.01	-	-	-	-	-
Currency Exchange Gain (Loss)	1,323	3,674	2,313	-168.55	3,022	-464.06
Other Non Operating Income (Expenses)	-50.58	-186.88	677.94	59.79	1,203	1,159
EBT Excluding Unusual Items	34,848	38,736	47,021	34,090	32,692	33,278
Gain (Loss) on Sale of Investments	1,648	1,437	2,552	368.74	805.62	2,580
Gain (Loss) on Sale of Assets	11.05	-6.36	-	-2.01	15.33	226.37
Asset Writedown	-	-	-	-	68.09	-
Pretax Income	36,507	40,167	49,572	34,457	33,581	36,084
Income Tax Expense	8,061	7,853	9,642	7,240	8,397	4,635
Earnings From Continuing Operations	28,447	32,314	39,930	27,217	25,184	31,449
Minority Interest in Earnings	-	-	-	50.01	134.14	29.21
Net Income	28,447	32,314	39,930	27,267	25,318	31,478
Net Income to Common	28,447	32,314	39,930	27,267	25,318	31,478
Net Income Growth	-20.52%	-19.07%	46.44%	7.70%	-19.57%	12.14%
Shares Outstanding (Basic)	49	49	49	49	49	49
Shares Outstanding (Diluted)	49	49	49	49	49	49
Shares Change (YoY)	-0.71%	-0.16%	0.13%	0.08%	-0.52%	-1.19%
EPS (Basic)	582.66	658.71	812.68	555.68	516.39	638.69
EPS (Diluted)	581.94	658.00	812.68	555.68	516.39	638.60
EPS Growth	-20.05%	-19.03%	46.25%	7.61%	-19.14%	13.48%
Free Cash Flow	11,930	-52,380	20,447	-29,225	47,970	9,696
Free Cash Flow Per Share	244.35	-1067.77	416.15	-595.58	978.39	196.72
Dividend Per Share	640.000	640.000	-	-	-	-
Gross Margin	69.01%	66.93%	73.60%	75.69%	76.91%	80.62%
Operating Margin	43.16%	41.47%	50.95%	48.63%	47.57%	53.03%
Profit Margin	36.54%	39.13%	50.41%	39.46%	42.85%	52.21%
Free Cash Flow Margin	15.32%	-63.42%	25.81%	-42.30%	81.18%	16.08%
EBITDA	38,414	39,406	45,342	37,053	30,145	34,062
EBITDA Margin	49.34%	47.72%	57.24%	53.62%	51.02%	56.49%
D&A For EBITDA	4,808	5,156	4,982	3,450	2,036	2,084
EBIT	33,605	34,250	40,360	33,603	28,109	31,978
EBIT Margin	43.16%	41.47%	50.95%	48.63%	47.57%	53.03%
Effective Tax Rate	22.08%	19.55%	19.45%	21.01%	25.00%	12.85%
Advertising Expenses	-	2,927	1,904	1,807	355.34	585.68

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.